The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preclinical development of tumor-infiltrating lymphocyte therapy for metastatic colorectal cancer.
 
Donastas Sakellariou-Thompson
No Relationships to Disclose
 
Marie-Andree Forget
No Relationships to Disclose
 
Jason Roszik
No Relationships to Disclose
 
Kyle R Jackson
No Relationships to Disclose
 
Young Uk Kim
No Relationships to Disclose
 
Shadarra Crosby
No Relationships to Disclose
 
Mark W Hurd
No Relationships to Disclose
 
Ji Wu
No Relationships to Disclose
 
Zhi-Qin Jiang
No Relationships to Disclose
 
Patrick Hwu
Stock and Other Ownership Interests - Immatics; Iovance Biotherapeutics
Consulting or Advisory Role - Dragonfly Therapeutics; GlaxoSmithKline; Immatics; Iovance Biotherapeutics; Sanofi
Research Funding - Genentech (Inst)
 
Gregory Lizee
No Relationships to Disclose
 
David Menter
No Relationships to Disclose
 
Scott Kopetz
Stock and Other Ownership Interests - MolecularMatch; Navire
Consulting or Advisory Role - Amgen; Array BioPharma; Bayer; EMD Serono; Genentech; Guardant Health (Inst); Karyopharm Therapeutics; Merck; Roche; Symphony Evolution
Research Funding - Amgen (Inst); Array BioPharma (Inst); Biocartis (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Guardant Health (Inst); MedImmune (Inst); Novartis (Inst); Sanofi (Inst)
 
Michael J. Overman
Consulting or Advisory Role - Bristol-Myers Squibb; Merrimack; Roche/Genentech
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; MedImmune; Merck; Roche
 
Cara L. Haymaker
Research Funding - Idera; Nektar
 
Chantale Bernatchez
Employment - Lexicon (I)
Stock and Other Ownership Interests - Lexicon (I)
Consulting or Advisory Role - Lion Biotechnologies
Research Funding - Idera; Nektar
Patents, Royalties, Other Intellectual Property - Patent pending on BTLA as a marker for better CD8 T cells for adoptive immunotherapy